1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Rhabdomyolysis in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YD | 1 |
| Zhang, L | 1 |
| Cai, GY | 1 |
| Zhang, XG | 1 |
| Lv, Y | 1 |
| Hong, Q | 1 |
| Shi, SZ | 1 |
| Yin, Z | 1 |
| Liu, XF | 1 |
| Chen, XM | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Rhabdomyolysis
| Article | Year |
|---|---|
Fasudil ameliorates rhabdomyolysis-induced acute kidney injury via inhibition of apoptosis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Kidney Injury; Animals; Apoptosis; Male; Protei | 2011 |